Kewalramani Reshma
Vertex Pharmaceuticals Inc · CEO & President
Kewalramani Reshma is listed in public filings as director, officer: CEO & President. This Kewalramani Reshma insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Vertex Pharmaceuticals Inc (VRTX), and Ginkgo Bioworks Holdings, Inc. (DNA). Investors use Kewalramani Reshma's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $857k1.7k shares | SellFeb 27, 2026 | $496.95 | -- | |
| $3.0M6k shares | SellFeb 27, 2026 | $496.16 | -- | |
| $7.7M15.6k shares | SellFeb 27, 2026 | $495.38 | -- | |
| $1.7M3.5k shares | SellFeb 27, 2026 | $494.33 | -- | |
| $1.2M2.5k shares | SellFeb 27, 2026 | $493.29 | -- | |
| $466k949 shares | SellFeb 27, 2026 | $491.30 | -- | |
| $1.3M2.7k shares | SellFeb 27, 2026 | $490.54 | -- | |
| $225k460 shares | SellFeb 27, 2026 | $489.32 | -- | |
| $1.6M3.3k shares | SellFeb 27, 2026 | $488.27 | -- | |
| $1.2M2.5k shares | SellFeb 27, 2026 | $487.13 | -- | |
| $116k240 shares | SellFeb 27, 2026 | $482.84 | -- | |
| $58k120 shares | SellFeb 27, 2026 | $481.50 | -- | |
| $192k400 shares | SellFeb 27, 2026 | $479.75 | -- |